Series B - New Haven Pharmaceuticals - Oct 23, 2014 Funding Round Profile - Cointime

Bitcoin $86,611.37 -2.25%
Ethereum $3,138.96 -5.81%
BNB $605.39 -6.31%
Optimism $1.53 -15.20%
Arbitrum $0.58 -13.49%
Solana $205.22 -6.19%
Polygon $0.37 -11.99%
Cosmos $4.95 -10.77%
Avalanche $31.78 -13.45%

Bitcoin $86,611.37 -2.25%
Ethereum $3,138.96 -5.81%
BNB $605.39 -6.31%
Optimism $1.53 -15.20%
Arbitrum $0.58 -13.49%
Solana $205.22 -6.19%
Polygon $0.37 -11.99%
Cosmos $4.95 -10.77%
Avalanche $31.78 -13.45%

New Haven Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 11.78M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail